false
0000797542
0000797542
2026-04-21
2026-04-21
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date
of report (date of earliest event reported): April 21, 2026
VIEWBIX
INC.
(Exact
Name of Registrant as Specified in its Charter)
Commission
File No.: 001-42681
| Delaware |
|
68-0080601 |
| (State
of Incorporation) |
|
(I.R.S.
Employer Identification No.) |
2
Jabotinsky St, Atrium Tower, 18th floor
Ramat
Gan, Israel 5252903 |
|
6971068 |
| (Address
of Registrant’s Office) |
|
(ZIP
Code) |
Registrant’s
Telephone Number, including area code: +972 9-774-1505
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under
any of the following provisions (see General Instruction A.2. below):
| ☐ |
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| |
|
| ☐ |
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| |
|
| ☐ |
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| |
|
| ☐ |
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities
registered pursuant to Section 12(b) of the Act:
| Title
of each class |
|
Trading
Symbol(s) |
|
Name
of each exchange on which registered |
| Common
Stock, par value $0.0001 per share |
|
VBIX |
|
The
Nasdaq Capital Market |
Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).
Emerging
growth company ☐
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
| Item
7.01 |
Regulation
FD Disclosure. |
On
April 21, 2026, Viewbix Inc., a Delaware corporation (the “Company”) issued a press release announcing a change of
the Company’s name from “Viewbix Inc.” to “Quantum X Labs Inc.” (the “Name Change”) and a change
of the Company’s trading symbol from “VBIX” to “QXL” on The Nasdaq Capital Market (the “Symbol Change”).
A copy of the press release is furnished hereto as Exhibit 99.1 and is incorporated herein by reference.
The
information in this Item 7.01, including the press release attached hereto as Exhibit 99.1, is being furnished under Item 7.01 of Form
8-K and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange
Act”) or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under
the Exchange Act, except as expressly set forth by specific reference in such filing.
In
connection with the Name Change and the Symbol Change, the Company’s common stock, par value $0.0001 per share (the “Common
Stock”), will begin trading on The Nasdaq Capital Market under the new ticker symbol “QXL,” effective as of the opening
of trading on April 30, 2026. The CUSIP number of the Common Stock will remain unchanged as a result of the Name Change and the Symbol
Change.
The
Name Change and Symbol Change do not affect the rights of the Company’s security holders. The Common Stock will continue to be
traded on The Nasdaq Stock Market. Following the Name Change, the stock certificates of the Common Stock, which reflect the former name
of the Company, will continue to be valid. Certificates reflecting the Name Change will be issued in due course as old stock certificates
are tendered for exchange or transfer to the Company’s transfer agent.
| Item
9.01 |
Financial
Statements and Exhibits. |
(d)
Exhibits
| Exhibit
No. |
|
Description |
| 99.1 |
|
Press
Release dated April 21, 2026 |
| 104 |
|
Cover
Page Interactive Data File (embedded within the Inline XBRL document) |
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its
behalf by the undersigned hereunto duly authorized.
| |
Viewbix
Inc. |
| |
|
|
| |
By: |
/s/
Amihay Hadad |
| |
Name:
|
Amihay
Hadad |
| |
Title: |
Chief
Executive Officer |
Date:
April 21, 2026
Exhibit
99.1

Viewbix
Announces Corporate Rebranding to Quantum X Labs: an Innovative Quantum and Technologies Company
Tel
Aviv, Israel, April 21, 2026, (GLOBE NEWSWIRE) — Viewbix Inc. (Nasdaq: VBIX) (“Viewbix” or the “Company”),
an advanced technologies company, today announced a comprehensive corporate rebranding to Quantum X Labs Inc. (“Quantum X Labs”).
The rebranding represents the Company’s evolution toward a leading company that develops and owns quantum computing technology
as well as a quantum error correction solution, quantum simulations and quantum sensing technologies, while continuing its legacy digital
advertising activities as a business segment.
The
Company is expected to change its name to Quantum X Labs Inc. and its ticker symbol to “QXL”, effective April 30th,
2026.
The
new name and brand aims to position Quantum X Labs as a leading company to research, develop, and potentially commercialize innovative
quantum solutions across key sectors, including navigation, precision timing, quantum algorithms, quantum error correction, drug
discovery, biomedicine, nuclear simulation, transportation, and quantum cyber security. At the heart of this evolution is the Company’s
wholly-owned subsidiary, Quantum X Labs Ltd., which the Company acquired in March 2026. This subsidiary operates as a dynamic quantum
technology company that hires top quantum experts with a robust proprietary intellectual property portfolio, including a pioneering
pending patent for AI-Quantum Error Correction and an active ecosystem of portfolio companies advancing breakthrough quantum applications.
Quantum
X Labs Ltd.’s portfolio companies include:
Quantum
Gyro: developing quantum-based gyroscope chip technology for unjammable, high-precision navigation systems designed to operate in GPS-denied
environments. Quantum Gyro is a 40%-owned subsidiary of Quantum X Labs Ltd.
Quantum
Atom Accuracy: advancing next-generation atomic clocks based on novel light-modulation schemes to deliver ultra-high accuracy, robustness,
and enhanced coherence for precision timing solutions. Quantum Atom Accuracy is a wholly-owned subsidiary of Nuclear Quantum.
Nuclear
Quantum: progressing quantum-powered simulation algorithms targeted at nuclear and engineering industries, with recent milestones moving
toward commercial engagement with leading simulation providers. Nuclear Quantum is a 40%-owned subsidiary of Quantum X Labs.
QunatumQ
Security: working on protecting assets by using quantum based cyber security. QuantumQ Security is a wholly-owned subsidiary of Quantum
Gyro.
Quantum
Transportation: developing transformer-based quantum decoder technology for advanced quantum error correction, including cloud-deployed
neural decoders and IP licensing from Ramot at Tel Aviv University, with applications in transportation and secure systems. Quantum Transportation
is a 30%-owned subsidiary of Quantum X Labs.
CliniQuantum:
applying quantum-enhanced methods (such as Markov Chain Monte Carlo) to drug discovery, clinical trial optimization, logistics, biomedicine,
and security sectors. CliniQuantum is a 46%-owned subsidiary of Quantum X Labs.
This
rebranding builds on a series of technical milestones achieved by its portfolio companies in recent months, including patent filings,
prototype breakthroughs in quantum gyroscopes and atomic clocks, and progress in quantum simulation and error-correction algorithms.
While
advancing its quantum innovation, the Company will continue to support its legacy business of digital advertising and AI-driven computing
solutions, through its subsidiaries Gix Media Ltd. and Metagramm Software Ltd., which complement its expanding quantum portfolio.
About
Viewbix Inc.
Viewbix
Inc. and its subsidiaries are focused on quantum technology, digital advertising and computing and enterprise artificial intelligence
(AI) solutions. Quantum X Labs is focused on developing and promoting quantum algorithms for the transportation, drug discovery and security
segments as well as developing quantum- based GPS replacement and quantum atom accuracy solutions. Gix Media develops a variety of technological
software solutions, which perform automation, optimization and monetization of internet campaigns, for the purposes of acquiring and
routing internet user traffic to its customers. Metagramm is a developer of grammatical error correction software and offers tools for
writing and reviewing, grammar, spelling, punctuation and style features, as well as translation and multilingual dictionaries, using
artificial intelligence and machine learning technology.
For
more information about Viewbix, visit https://view-bix.com/
About
Quantum X Labs
Quantum
X Labs is an Israel-based multi-disciplinary quantum technology company focused on the research, development, and commercialization
of advanced quantum technologies and intellectual property. The company operates across a broad range of domains, including quantum computing,
quantum sensing, navigation systems, atomic clocks, and quantum algorithms, with applications spanning defense, aerospace, transportation,
cybersecurity, and life sciences.
Forward-Looking
Statements
This
press release contains forward-looking statements within the meaning of the “safe harbor” provisions of the Private Securities
Litigation Reform Act of 1995 and other Federal securities laws. Words such as “expects,” “anticipates,” “intends,”
“plans,” “believes,” “seeks,” “estimates” and similar expressions or variations of such
words are intended to identify forward-looking statements. For example, the Company is using forward-looking statements when it discusses
the Company’s future plans, strategies and expectations, including the research, development, and potential commercialization of
innovative quantum solutions across key sectors, including computing technologies, navigation, precision timing, quantum algorithms,
error correction, drug discovery, biomedicine, nuclear simulation, transportation, and quantum cyber security. Because such statements
deal with future events and are based on Viewbix’s current expectations, they are subject to various risks and uncertainties, and
actual results, performance or achievements could differ materially from those described in or implied by the statements in this press
release.
The
forward-looking statements contained or implied in this press release are subject to other risks and uncertainties, including those discussed
in any filings with the SEC. Except as otherwise required by law, Viewbix undertakes no obligation to publicly release any revisions
to these forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated
events. References and links to websites have been provided as a convenience, and the information contained on such websites is not incorporated
by reference into this press release. Viewbix is not responsible for the contents of third-party websites.
Investor
Relations Contacts:
Michal
Efraty
Investor
Relations
michal@efraty.com